Australia - angielski - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - fluorescein sodium -

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - fluorescein sodium - eye drops solution - 1 %w/v - fluorescein

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - fluorescein sodium - eye drops solution - 2.0 %w/v - fluorescein

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

nomax inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescein 0.12 mg - for testing tear film stability by determining the fluorescein break-up time (fbut). hypersensitivity to components or mercury-containing compounds.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

bausch & lomb incorporated - benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303), fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - benoxinate hydrochloride 4 mg in 1 ml - for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product. prolonged use of a topical ocular anesthetic is not recommended. it may produce permanent corneal opacification with accompanying visual loss.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

ocusoft, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - flourescein sodium and benoxinate hydrochloride opthalmic solution usp, 0.25%/0.4% is a disclosing agent with rapid anesthetic action of short duration. fluorescein sodium is represented by the following structural formula: chemical name: spiro  [isobenzofuran-1  (3h ),9'-[9h ]  xanthene]-3-one,  3',6'  dihydroxy, disodium salt. benoxinate hydrochloride is represented by the following structural formula: chemical name: 2-(diethylamino) ethyl 4-amino-3butoxybenzoate monohydrochloride. for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures. known hypersensitivity to any component of this product.

Kanada - angielski - Health Canada

odan laboratories ltd - fluorescein sodium - solution - 100mg - fluorescein sodium 100mg - other diagnostic agents

Kanada - angielski - Health Canada

odan laboratories ltd - fluorescein sodium - liquid - 250mg - fluorescein sodium 250mg - other diagnostic agents

Australia - angielski - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 40 mg/ml; fluorescein sodium, quantity: 2.5 mg/ml - eye drops, solution - excipient ingredients: purified water; hydrochloric acid; povidone - as a diagnostic stain and topical anaesthetic combined, minims lignocaine and fluorescein is intended primarily to facilitate goldmann applanation tonometry.

Singapur - angielski - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - fluorescein sodium - injection, solution - 0.5g/5ml - fluorescein sodium 0.5g/5ml